MEDICOX Statistics

Total Valuation

MEDICOX has a market cap or net worth of KRW 12.68 billion. The enterprise value is 20.33 billion.

Market Cap	12.68B
Enterprise Value	20.33B

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDICOX has 5.52 million shares outstanding. The number of shares has decreased by -93.54% in one year.

Current Share Class	5.52M
Shares Outstanding	5.52M
Shares Change (YoY)	-93.54%
Shares Change (QoQ)	-93.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.43
PB Ratio	0.25
P/TBV Ratio	0.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.29
EV / Sales	0.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.32

Financial Position

The company has a current ratio of 0.60, with a Debt / Equity ratio of 0.23.

Current Ratio	0.60
Quick Ratio	0.33
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	-2.52
Interest Coverage	-3.43

Financial Efficiency

Return on equity (ROE) is -31.08% and return on invested capital (ROIC) is -5.68%.

Return on Equity (ROE)	-31.08%
Return on Assets (ROA)	-5.00%
Return on Invested Capital (ROIC)	-5.68%
Return on Capital Employed (ROCE)	-10.73%
Revenue Per Employee	473.47M
Profits Per Employee	-254.84M
Employee Count	38
Asset Turnover	0.39
Inventory Turnover	15.86

Taxes

Income Tax	-72.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.91% in the last 52 weeks. The beta is -0.20, so MEDICOX's price volatility has been lower than the market average.

Beta (5Y)	-0.20
52-Week Price Change	-75.91%
50-Day Moving Average	2,911.20
200-Day Moving Average	4,459.80
Relative Strength Index (RSI)	41.36
Average Volume (20 Days)	865,845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDICOX had revenue of KRW 29.36 billion and -15.80 billion in losses. Loss per share was -5,641.00.

Revenue	29.36B
Gross Profit	2.67B
Operating Income	-6.06B
Pretax Income	-15.87B
Net Income	-15.80B
EBITDA	-4.61B
EBIT	-6.06B
Loss Per Share	-5,641.00

Full Income Statement

Balance Sheet

The company has 3.65 billion in cash and 11.85 billion in debt, giving a net cash position of -8.20 billion or -1,484.34 per share.

Cash & Cash Equivalents	3.65B
Total Debt	11.85B
Net Cash	-8.20B
Net Cash Per Share	-1,484.34
Equity (Book Value)	50.64B
Book Value Per Share	4,780.18
Working Capital	-6.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.88 billion and capital expenditures -824.39 million, giving a free cash flow of -4.71 billion.

Operating Cash Flow	-3.88B
Capital Expenditures	-824.39M
Free Cash Flow	-4.71B
FCF Per Share	-852.18

Full Cash Flow Statement

Margins

Gross margin is 9.10%, with operating and profit margins of -20.64% and -53.82%.

Gross Margin	9.10%
Operating Margin	-20.64%
Pretax Margin	-54.07%
Profit Margin	-53.82%
EBITDA Margin	-15.69%
EBIT Margin	-20.64%
FCF Margin	n/a

Dividends & Yields

MEDICOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	93.54%
Shareholder Yield	93.54%
Earnings Yield	-124.61%
FCF Yield	-37.13%

Stock Splits

The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 16, 2022
Split Type	Forward
Split Ratio	2

Scores

MEDICOX has an Altman Z-Score of -0.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.72
Piotroski F-Score	3